Testing effectiveness (Phase 2)UnknownNCT02117765What this trial is testingPilot Clinical Trial of Ustekinumab in Patients With New-onset T1DWho this might be right forType 1 Diabetes University of British Columbia 20
Testing effectiveness (Phase 2)Study completedNCT01536431What this trial is testingSafety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 DiabetesWho this might be right forType 1 Diabetes Cardiff University 27
Large-scale testing (Phase 3)Active Not RecruitingNCT03941132What this trial is testingClinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)Who this might be right forType 1 Diabetes Mellitus University of British Columbia 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT03929601What this trial is testingRituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 DiabetesWho this might be right forType 1 Diabetes Mellitus National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 74
Large-scale testing (Phase 3)Study completedNCT00678886What this trial is testingTrial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1Who this might be right forDiabetes Mellitus, Type 1 GlaxoSmithKline 272
Not applicableNot Yet RecruitingNCT06586632What this trial is testingThe Steno Free Trial: AID to Adults with New-onset of Type 1 DiabetesWho this might be right forType 1 Diabetes University of Aarhus 60
Testing effectiveness (Phase 2)Study completedNCT02218619What this trial is testingTauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 DiabetesWho this might be right forType 1 Diabetes Robin Goland, MD 20
Not applicableUnknownNCT06157736What this trial is testingMicrobiome in the Acute Stage of New Onset Paediatric Type 1 DiabetesWho this might be right forType 1 Diabetes University College Cork 100
Testing effectiveness (Phase 2)Ended earlyNCT02093221What this trial is testingStudy of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes MellitusWho this might be right forType 1 Diabetes Mellitus Grifols Therapeutics LLC 76
Testing effectiveness (Phase 2)UnknownNCT01947569What this trial is testingDendritic Cells for Type 1 Diabetes Mellitus (T1DM) TherapyWho this might be right forTreatment of Type I Diabetes Mellitus. DiaVacs, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT00730392What this trial is testingEtanercept in New Onset Type 1 DiabetesWho this might be right forType 1 Diabetes State University of New York at Buffalo 18
Large-scale testing (Phase 3)WithdrawnNCT01762644What this trial is testingThe Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes PatientsWho this might be right forType 1 Diabetes Perle Bioscience, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT04589325What this trial is testingIxekizumab Diabetes Intervention Trial (I-DIT)Who this might be right forType1 Diabetes Mellitus Göteborg University 127
Not applicableActive Not RecruitingNCT04007809What this trial is testingPhenotypic and Genotypic Characterization of New-onset Type I DiabetesWho this might be right forType1diabetes Université Catholique de Louvain 98
Testing effectiveness (Phase 2)WithdrawnNCT01183455What this trial is testingA Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part IIWho this might be right forDiabetes Mellitus, Type 1 National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00960635What this trial is testingImmunointervention With Calcitriol in New-Onset Type 1 DiabetesWho this might be right forType 1 Diabetes Institut fur Diabetesforschung, Munich, Germany
Early research (Phase 1)Study completedNCT00873561What this trial is testingEvaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes MellitusWho this might be right forType 1 Diabetes Mellitus Neurocrine Biosciences 188
Testing effectiveness (Phase 2)Looking for participantsNCT07061574What this trial is testingPhase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 DiabetesWho this might be right forType 1 DiabetesNew Onset City of Hope Medical Center 120
Testing effectiveness (Phase 2)Ended earlyNCT00837759What this trial is testingNovel Therapy to Preserve Beta Cell Function in New Onset Type 1 DiabetesWho this might be right forDiabetes Mellitus Type 1Autoimmune Diabetes National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 7
Testing effectiveness (Phase 2)Ended earlyNCT00965458What this trial is testingInducing Remission in Type 1 Diabetes With AlefaceptWho this might be right forNew-onset Type 1 Diabetes Mellitus National Institute of Allergy and Infectious Diseases (NIAID) 49